Delays to care in infantile epileptic spasms syndrome: Racial and ethnic inequities

Christina Briscoe Abath1, Nishtha Gupta1, Aristides Hadjinicolaou2

  • 1Department of Neurology, Comprehensive Epilepsy Program, Division of Epilepsy, Boston Children's Hospital, Boston, Massachusetts, USA.

Epilepsia
|November 12, 2023
PubMed

Insights

Children from racial/ethnic minority backgrounds experience longer diagnostic delays for infantile epileptic spasms syndrome (IESS). These delays in diagnosing IESS can negatively impact developmental outcomes.

Area of Science:

  • Pediatric Neurology
  • Child Development
  • Health Equity

Background:

  • Infantile epileptic spasms syndrome (IESS) is a rare epilepsy syndrome in infants.
  • Standard treatment for IESS is often delayed in Non-Hispanic (NH) Black children compared to White/NH children.
  • The impact of diagnostic delays on IESS outcomes is not well understood.

Purpose of the Study:

  • To investigate potential inequities in the time to diagnosis for infantile epileptic spasms syndrome (IESS).
  • To compare diagnostic delays between racial/ethnic groups in pediatric epilepsy centers.

Main Methods:

  • Retrospective cohort study of 100 children with new-onset IESS between January 2019 and May 2022.
  • Evaluation of diagnostic delays, including referral time from the first provider to a neurologist.

Main Results:

  • Children with Black, Indigenous, and People of Color (BIPOC) caregivers faced significantly longer delays in referral to a neurologist compared to White/NH children.
  • These delays persisted even after controlling for demographic and clinical variables (OR=4.98, CI=1.24-19.94, p=.023).

Conclusions:

  • Disproportionate diagnostic delays for IESS place BIPOC children at increased risk for adverse developmental and epilepsy outcomes.
  • Further research, including prospective and qualitative studies, is necessary to address these healthcare inequities.
Abstract